Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 nivolumab + ipilimumab in previously treated classical Kaposi sarcoma
MOH_2018-08-09_000585Phase 2Recruiting
- Sponsor
- ד"ר אלונה זר
- Start
- Mar 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nivolumab and ipilimumab in Classical Kaposi Sarcoma, sponsored by ד"ר אלונה זר. Started Mar 2017; status: recruiting.
02
Drugs
nivolumabipilimumab
03
Conditions
Classical Kaposi Sarcoma
Beyond the preview
Go deeper on MOH_2018-08-09_000585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-08-09_000585.